Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation

Rahil Eftekhari, Stacy G.De Lima, Yu Liu, Koichiro Mihara, Mahmoud Saifeddine, Farshid Noorbakhsh, Isobel A Scarisbrick, Morley D. Hollenberg

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We propose that in the microenvironment of inflammatory tissues, including tumours, extracellular proteinases can modulate cell signalling in part by regulating proteinaseactivated receptors (PARs). We have been exploring this mechanism in a variety of inflammation and tumour-related settings that include tumour-derived cultured cells from prostate and bladder cancer, as well as immune inflammatory cells that are involved in the pathology of inflammatory diseases including multiple sclerosis. Our work shows that proteinase signalling via the PARs affects prostate and bladder cancer-derived tumour cell behaviour and can regulate calcium signalling in human T-cell and macrophage-related inflammatory cells as well as in murine splenocytes. Further, we find that the tumour-derived prostate cancer cells and immune-related cells (Jurkat, THP1, mouse splenocytes) can produce PAR-regulating proteinases (including kallikreins: KLKs), that can control tissue function by both a paracrine and autocrine mechanism. We suggest that this PAR-driven signalling process involving secreted microenvironment proteinases can play a key role in cancer and inflammatory diseases including multiple sclerosis.

Original languageEnglish (US)
JournalBiological Chemistry
DOIs
StateAccepted/In press - Jun 20 2018

Fingerprint

Proteinase-Activated Receptors
Tumors
Peptide Hydrolases
Inflammation
Prostatic Neoplasms
Cells
Neoplasms
Urinary Bladder Neoplasms
Multiple Sclerosis
Tissue
Cultured Tumor Cells
Cell signaling
Kallikreins
Jurkat Cells
Calcium Signaling
T-cells
Macrophages
Pathology
Calcium
T-Lymphocytes

Keywords

  • bladder cancer
  • microenvironment proteinases
  • multiple sclerosis
  • prostate cancer
  • proteinase-activated receptors (PARs)
  • T-cells/macrophages/splenocytes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Eftekhari, R., Lima, S. G. D., Liu, Y., Mihara, K., Saifeddine, M., Noorbakhsh, F., ... Hollenberg, M. D. (Accepted/In press). Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation. Biological Chemistry. https://doi.org/10.1515/hsz-2018-0001

Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation. / Eftekhari, Rahil; Lima, Stacy G.De; Liu, Yu; Mihara, Koichiro; Saifeddine, Mahmoud; Noorbakhsh, Farshid; Scarisbrick, Isobel A; Hollenberg, Morley D.

In: Biological Chemistry, 20.06.2018.

Research output: Contribution to journalArticle

Eftekhari, Rahil ; Lima, Stacy G.De ; Liu, Yu ; Mihara, Koichiro ; Saifeddine, Mahmoud ; Noorbakhsh, Farshid ; Scarisbrick, Isobel A ; Hollenberg, Morley D. / Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation. In: Biological Chemistry. 2018.
@article{b6d8a3e1f71541c4be3f2cd085dc9b30,
title = "Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation",
abstract = "We propose that in the microenvironment of inflammatory tissues, including tumours, extracellular proteinases can modulate cell signalling in part by regulating proteinaseactivated receptors (PARs). We have been exploring this mechanism in a variety of inflammation and tumour-related settings that include tumour-derived cultured cells from prostate and bladder cancer, as well as immune inflammatory cells that are involved in the pathology of inflammatory diseases including multiple sclerosis. Our work shows that proteinase signalling via the PARs affects prostate and bladder cancer-derived tumour cell behaviour and can regulate calcium signalling in human T-cell and macrophage-related inflammatory cells as well as in murine splenocytes. Further, we find that the tumour-derived prostate cancer cells and immune-related cells (Jurkat, THP1, mouse splenocytes) can produce PAR-regulating proteinases (including kallikreins: KLKs), that can control tissue function by both a paracrine and autocrine mechanism. We suggest that this PAR-driven signalling process involving secreted microenvironment proteinases can play a key role in cancer and inflammatory diseases including multiple sclerosis.",
keywords = "bladder cancer, microenvironment proteinases, multiple sclerosis, prostate cancer, proteinase-activated receptors (PARs), T-cells/macrophages/splenocytes",
author = "Rahil Eftekhari and Lima, {Stacy G.De} and Yu Liu and Koichiro Mihara and Mahmoud Saifeddine and Farshid Noorbakhsh and Scarisbrick, {Isobel A} and Hollenberg, {Morley D.}",
year = "2018",
month = "6",
day = "20",
doi = "10.1515/hsz-2018-0001",
language = "English (US)",
journal = "Biological Chemistry",
issn = "1431-6730",
publisher = "Walter de Gruyter GmbH & Co. KG",

}

TY - JOUR

T1 - Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation

AU - Eftekhari, Rahil

AU - Lima, Stacy G.De

AU - Liu, Yu

AU - Mihara, Koichiro

AU - Saifeddine, Mahmoud

AU - Noorbakhsh, Farshid

AU - Scarisbrick, Isobel A

AU - Hollenberg, Morley D.

PY - 2018/6/20

Y1 - 2018/6/20

N2 - We propose that in the microenvironment of inflammatory tissues, including tumours, extracellular proteinases can modulate cell signalling in part by regulating proteinaseactivated receptors (PARs). We have been exploring this mechanism in a variety of inflammation and tumour-related settings that include tumour-derived cultured cells from prostate and bladder cancer, as well as immune inflammatory cells that are involved in the pathology of inflammatory diseases including multiple sclerosis. Our work shows that proteinase signalling via the PARs affects prostate and bladder cancer-derived tumour cell behaviour and can regulate calcium signalling in human T-cell and macrophage-related inflammatory cells as well as in murine splenocytes. Further, we find that the tumour-derived prostate cancer cells and immune-related cells (Jurkat, THP1, mouse splenocytes) can produce PAR-regulating proteinases (including kallikreins: KLKs), that can control tissue function by both a paracrine and autocrine mechanism. We suggest that this PAR-driven signalling process involving secreted microenvironment proteinases can play a key role in cancer and inflammatory diseases including multiple sclerosis.

AB - We propose that in the microenvironment of inflammatory tissues, including tumours, extracellular proteinases can modulate cell signalling in part by regulating proteinaseactivated receptors (PARs). We have been exploring this mechanism in a variety of inflammation and tumour-related settings that include tumour-derived cultured cells from prostate and bladder cancer, as well as immune inflammatory cells that are involved in the pathology of inflammatory diseases including multiple sclerosis. Our work shows that proteinase signalling via the PARs affects prostate and bladder cancer-derived tumour cell behaviour and can regulate calcium signalling in human T-cell and macrophage-related inflammatory cells as well as in murine splenocytes. Further, we find that the tumour-derived prostate cancer cells and immune-related cells (Jurkat, THP1, mouse splenocytes) can produce PAR-regulating proteinases (including kallikreins: KLKs), that can control tissue function by both a paracrine and autocrine mechanism. We suggest that this PAR-driven signalling process involving secreted microenvironment proteinases can play a key role in cancer and inflammatory diseases including multiple sclerosis.

KW - bladder cancer

KW - microenvironment proteinases

KW - multiple sclerosis

KW - prostate cancer

KW - proteinase-activated receptors (PARs)

KW - T-cells/macrophages/splenocytes

UR - http://www.scopus.com/inward/record.url?scp=85049137145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049137145&partnerID=8YFLogxK

U2 - 10.1515/hsz-2018-0001

DO - 10.1515/hsz-2018-0001

M3 - Article

C2 - 29924723

AN - SCOPUS:85049137145

JO - Biological Chemistry

JF - Biological Chemistry

SN - 1431-6730

ER -